title: Lack of concordance in the use and monitoring of intravenous aminoglycosides in UK cystic fibrosis centers.
authors.forename: Kelvin H-V
authors.initials: KH
authors.lastname: Tan
authors.forename: Pauline
authors.initials: P
authors.lastname: Hyman-Tylor
authors.forename: Mike
authors.initials: M
authors.lastname: Mulheran
authors.forename: Alan
authors.initials: A
authors.lastname: Knox
authors.forename: Alan
authors.initials: A
authors.lastname: Smyth
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003550:Cystic Fibrosis / Q000150:complications; D003638:Deafness / Q000139:chemically induced; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy*; D014031:Tobramycin / Q000008:administration & dosage* / Q000009:adverse effects; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents; D014031:Tobramycin